Synthesis and Pharmacological Examination of Benzofuran, Indan, and Tetralin Analogues of 3,4-(Methylenedioxy)amphetamine

Journal of Medicinal Chemistry

Volumn 36, Issue 23, 1993, Pages 3700-3706

  Monte, Aaron P ^a   Marona Lewicka, Danuta ^a   Cozzi, Nicholas V ^a   Nichols, David E ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BENZOFURAN DERIVATIVE; DOPAMINE; DRUG ANALOG; INDAN DERIVATIVE; LYSERGIDE; NEUROTRANSMITTER; NORADRENALIN; OXYGEN; PARGYLINE; SEROTONIN; SODIUM CHLORIDE; TETRALIN DERIVATIVE;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG POTENCY; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; REINFORCEMENT; STRUCTURE ACTIVITY RELATION; SYNAPTOSOME; TRAINING;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMAL; BENZOFURANS; BRAIN; DISCRIMINATION LEARNING; DOPAMINE; INDENES; MALE; MOLECULAR STRUCTURE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPTOSOMES; TETRAHYDRONAPHTHALENES;

EID: 0027135576     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00075a027     Document Type: Article

References (33)

1. Anderson, G. M., III; Braun, G.; Braun, U.; Nicholas, D. E.; Shulgin, A. T. Absolute Configuration and Psychotomimetic Activity. In QuaSAR Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonistss, and Hallucinogens. National Institute on Drug Abuse Research Monograph; Barnett, G.; Trsic, M.; Willette, R., Eds.; U.S. Government Printing Office: Washington, D.C., 1978, Vol. 22, pp 27–32.
2. Fitzgerald, J. L.; Reid, J. J. Interactions of Methylenedioxymetham-phetamine with Monoamine Transmitter Release Mechanisms in Rat Brain Slices. Naunyn-Schmiedeberg'sArch. Pharmacol. 1993, 347, 313–323.
3. 2 Receptors. Psychopharmacology 1986, 88, 525–526.
4. Nichols, D. E.; Hoffman, A. J.; Oberlender, R. A.; Jacob, P., III; Shulgin, A. T. Derivatives of 1-(1,3-Benzodioxol-5-yl)-2-butanamine: Representatives of a Novel Therapeutic Class. J. Med. Chem. 1986, 29, 2009–2015.
5. Nichols, D. E. Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. J. Psychoact. Drugs 1986, 18, 305–313.
6. Nichols, D. E.; Oberlender, R. Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs? Ann. N.Y. Acad. Sci. 1990, 600, 613–625.
7. Oberlender, R.; Nichols, D. E. Drug Discrimination Studies With MDMA and Amphetamine. Psychopharmacology 1988, 95, 71–76.
8. Oberlender, R.; Nichols, D. E. (+)-N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-Methylenedioxymethamphetamine-Like Behavioral Activity. J. Pharmacol. Exp. Ther. 1990, 255, 1098–1106.
9. Shulgin, A. T. The Background and Chemistry of MDMA. J. Psychoact. Drugs 1986, 18, 291–304.
10. Steele, T. D.; Nichols, D. E.; Yim, G. K. W. Stereochemical Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Related Amphetamine Derivatives on Inhibition of Uptake of [3H]-Monoamines into Synaptosomes from Different Regions of Rat Brain. Biochem. Pharmacol. 1987, 36, 2297–2303.
11. Peroutka, S. J.; Newman, H.; Harris, H. Subjective Effects of 3,4-Methylenedioxymethamphetamine in Recreational Users. Neu-ropsychopharmacology 1988, 1, 273–277.
12. Weil, A. T. Letters from Andrew Weil. The Love Drug. J. Psychedelic Drugs 1976, 8, 335–337.
13. Greer, G.; Tolbert, R. Subjective Reports of the Effects of MDMA in a Clinical Setting. J. Psychoact. Drugs 1986, 18, 319–327.
14. Trager, J. A Place for Ecstasy in Psychotherapy? Med. Tribune 1988, 29, 12–14.
15. Wolfson, P. E. Meetings at the Edge with Adam: A Man for All Seasons. J. Psychoact. Drugs 1986, 18, 329–333.
16. Schmidt, C. J.; Wu, L.; Lovenberg, W. Methylenedioxy-methamphetamine: A Potentially Neurotoxic Amphetamine Analogue. Eur. J. Pharmacol. 1986, 124, 175–178.
17. Stone, D. A.; Stahl, D. C.; Hanson, G. R.; Gibb, J. W. The Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA) on Monoaminergic Systems in the Rat Brain. Eur. J. Pharmacol. 1986, 128, 41–48.
18. Ricaurte, G. A.; Forno, L. S.; Wilson, M. A.; DeLanney, L. E.; Irwin, I.; Molliver, M. E.; Langston, J. W. 3,4-Methylenedioxymetham-phetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates. J. Am. Med. Assoc. 1988, 260, 51–55.
19. Ricaurte, G.; Delanney, L. E.; Irwin, I.; Langsten, J. W. Toxic Effects of MDMA on Central Serotonergic Neurons in the Primate: Importance of Route and Frequency of Drug Administration. Brain Res. 1988, 446, 165–168.
20. Johnson, M. P.; Huang, X.; Nichols, D. E. Serotonin Neurotoxicity in Rats After Combined Treatment With a Dopaminergic Agent Followed by a Nonneurotoxic 3,4-Methylenedioxymethamphet-amine (MDMA) Analogue. Pharmacol. Biochem. Behau. 1991, 40, 915–922.
21. Nichols, D. E.; Marona-Lewicka, D.; Huang, X.; Johnson, M. P. Novel Serotonergic Agents. Drug Des. Discovery 1993, 9, 299–312.
22. Johnson, M. P.; Frescas, S. P.; Oberlender, R.; Nichols, D. E. Synthesis and Pharmacological Examination of 1-(3-Methoxy-4-methylphenyl)-2-aminopropane and 5-Methoxy-6-methyl-2-aminoindan: Similarities to 3,4-(Methylenedioxy)methamphet-amine (MDMA). J. Med. Chem. 1991, 34, 1662–1668.
23. 3H]Monoamine Releasing and Uptake Inhibition Properties of 3,4-Methylene-dioxymethamphetamine and p-Chloroamphetamine analogues. Eur. J. Pharmacol. 1991, 200, 9–16.
24. Nichols, D. E.; Brewster, W. K.; Johnson, M. P.; Oberlender, R.; Riggs, R. M. Nonneurotoxic Tetralin and Indan Analogues of 3,4-(Methylenedioxy)amphetamine (MDA). J. Med. Chem. 1990, 33, 703–710.
25. Toyoda, T.; Sasakura, K.; Sugasawa, T. Exclusive Ortho α-Chlo-roacetylation of Phenols. J. Org. Chem. 1981, 46, 189–191.
26. Hammond, M. L.; Zambias, R. A.; Chang, M. N.; Jensen, N. P.; McDonald, J.; Thompson, K.; Boulton, D. A.; Kopka, I. E.; Hand, K. M.; Opas, E. E.; Luell, S.; Bach, T.; Davies, P.; MacIntyre, D. E.; Bonney, R. J.; Humes, J. L. Antioxidant-Based Inhibitors of Leukotriene Biosynthesis. The Discovery of 6-[1-[2-(Hydroxy-methyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5-benzofuranol, a Potent Topical Antiinflammatory Agent. J. Med. Chem. 1990, 33, 908–918.
27. Nichols, D. E.; Oberlender, R. Structure-activity Relationships of MDMA and Related Compounds, a New Class of Psychoactive Agents. In Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA; Peroutka, S. J., Eds.; Kluwer Academic Publishers: Boston, 1990.
28. 2 Receptor-mediated Potentiation of Dopamine Synthesis and Serotonergic Neurotoxicity. Eur. J. Pharmacol. 1993, in press.
29. Shulgin, A. T.; Shulgin, A. Pihkal: A Chemical Love Story. Transform Press: Berkeley, 1992.
30. Eggler, J. F.; Holland, G. F.; Johnson, M. R.; Volkmann, R. A. Hypoglycemic Thiazolidineones. United States Patent 4,703,052, October 27, 1987.
31. Wightman, R. H.; Laycock, D. E.; Avdovich, H. W. Chloromethylation of Ortho-Disubstituted Benzenes. A Simple Preparation of Some Useful α Isomers of Indan, Tetralin, and Benzosuberane. J. Org. Chem. 1978, 43, 2167–2170.
32. Litchfield, J. T.; Wilcoxon, F. A Simplified Method of Evaluating Dose-Effect Experiments. J. Pharmacol. Expt. Ther. 1949, 96, 99–113.
33. McPherson, G. A. Analysis of Radioligand Binding Experimente: A Collection of Computer Programs for the IBM PC. J. Pharmacol. Methods 1985, 14, 213–228.